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Abstract
Background: There are social and economic differences between Northern Ireland (NI) and the Republic of Ireland
(ROI). There are also differences in the health care systems in the two jurisdictions. The aims of this study are to
compare health (prevalence of diabetes and related complications) and health care utilisation (general practitioner,
outpatient or accident and emergency utilisation) among older people with diabetes in the NI and ROI.
Methods: Large scale comparable surveys of people over 50 years of age in Northern Ireland (NICOLA, wave 1) and
the Republic of Ireland (TILDA, wave 1) are used to compare people with diabetes (type I and type II) in the two
jurisdictions. The combined data set comprises 1536 people with diabetes. A coarsened exact matching approach is
used to compare health care utilisation among people with diabetes in NI and ROI with equivalent demographic,
lifestyle and illness characteristics (age, gender, education, smoking status and self-related health, number of other
chronic diseases and number of diabetic complications).
Results: The overall prevalence of diabetes in the 50 to 84 years old age group is 3.4 percentage points higher in
NI (11.1% in NI, 7.7% ROI, p-value < 0.01). The diabetic population in NI appear sicker – with more diabetic
complications and more chronic illnesses. Comparing people with diabetes in the two jurisdictions with similar
levels of illness we find that there are no statistically significant differences in GP, outpatient or A&E utilisation.
Conclusion: Despite the proximity of NI and ROI there are substantial differences in the prevalence of diabetes and
its related complications. Despite differences in the health services in the two jurisdictions the differences in health
care utilisation for an equivalent cohort are small.
Keywords: Diabetes, Complications, Health care utilisation, Quality and outcomes framework
Background
Diabetic care is a substantial driver of overall health care
utilisation and costs. In Europe and North America, the
proportion of health care expenditure on diabetes in
2010 ranges from 6 to 14% [1]. In the Republic of
Ireland, the incremental cost of additional health service
use is estimated to be €89 million annually [2]. Health
care utilisation and health care costs among those with
diabetes are strongly related to diabetic complications; in
the UK, 80% of diabetic health care costs are due to
complications [3, 4]. In addition to direct health care
costs, diabetes significantly impacts on mortality rates,
quality of life and labour market productivity [5, 6].
It is currently difficult to make direct comparisons be-
tween the prevalence of diabetes in Northern Ireland
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(NI) and Republic of Ireland (ROI). In Northern Ireland
(NI), based on register data, 5.6% of the population aged
18 and over have diabetes [7]. While in ROI a similar
register does not exist, it has been estimated that 5.2% of
those aged 18 and over have diabetes [8]. However,
given the strong relationship between diabetes preva-
lence, age and gender comparing these two figures is
problematic. A previous study, based on prescribing da-
tabases in the two jurisdictions found clinically equiva-
lent prevalence rates of diabetes in NI and ROI across
all age groups [9].
NI and ROI have operate different health care systems.
In both, the GP is the primary point of contact between
the health service and people with diabetes. However,
there are differences in the way that GP services are de-
livered in NI and ROI. In NI practices provide publicly
funded care, free at the point of use, to a defined list of
patients on a universal basis. The Quality Outcomes
Framework (QOF) system, in place from 2004, provides
financial incentives for GPs to maintain disease registers
and meet quality indicators. The QOF system resulted in
three simultaneous changes: better data collection by
GPs, public information on the quality of care, and pay
for performance [10]. For diabetes, GPs receive add-
itional payment for having higher proportions of patients
with biomarkers such as blood pressure, lipids and blood
sugar in specified ranges as well as records of screening/
examinations [11]. However, beyond the upper thresh-
olds of each QOF indicator, GPs receive no additional fi-
nancial reward to improve care [12]. In the UK QOF has
been shown to be associated with improvements in both
process and outcomes of diabetes care [13].
In ROI, GPs have a mix of publicly funded and private
fee paying patients. The mixed nature of GP care in ROI
means that GPs who see additional private patients can
generate more revenue [14]. In contrast in NI, private
patients as a potential revenue stream do not exist. In
ROI, at the time the data for this study were collected
(2011), there was no specific financial support for GPs
providing primary care to patients with diabetes. While
several diabetes initiatives were in place in Ireland, dia-
betic care was frequently unstructured and record keep-
ing by many GPs was poor [15, 16]. However, structured
reviews and record keeping are only one component of
quality primary care. Access and quality of interaction in
GP consultations, continuity of care, and access to prac-
tice nurses are important components of care quality
[17–19]. The supply of GPs has been shown internation-
ally to be associated with improved outcomes, such as
reduced mortality [20]. In this context it is notable that
there are fewer GPs in NI per capita than in ROI; the
average GP list size was 1620 in NI in 2014 [21] and
1175 in ROI (1335 based on Whole Time Equivalent,
WTE), based on total number (head count) of GPs for
2014 and population numbers [22]. While we do not
have WTE values for GPs in NI, even if all GPs were
working on a full time basis in NI, there would still be
more supply in ROI. Differences in the supply of GPs
may result in shorter consultation durations [23, 24] and
longer waiting times for non-emergency consultations in
NI, as in the rest of the UK [25, 26]. Practice nurses play
an increasingly important role in the provision of pri-
mary care [27]. As with GPs there are more practice
nurses per capita in ROI. In ROI there are 0.26 practice
nurses per 1000, this compares with an average of 0.2 in
NI [22, 28, 29].
Cost has been shown to be an important factor in the
demand for GP care [30]. While GP care is free at the
point of use for patients in Northern Ireland, a substan-
tial minority (31.5%) of people in ROI with diabetes are
not covered by the medical card or GP visit card
schemes and will have to pay for their GP care [31]. For
those who have to pay out of pocket for a GP consult-
ation, the cost of a consultation is in the region of €50,
which may represent a significant deterrent to attending
[32, 33]. While the cost of attending the GP may be a
deterrent for some people it may, by reducing demand,
reduce capacity constraints that permit easier access for
others [14].
The approach to outpatient diabetes care varies widely
across public hospitals in ROI in terms of the dischar-
ging of uncomplicated cases back to primary care [34].
There is also substantial variation in waiting lists across
hospitals for outpatient care. All patients have access to
free public outpatient diabetes care but non-medical
card holders (those who have to pay to access GP care)
usually have to pay for diabetes services provided by
their GP [34]. This can result in a reluctance by some
patients to be discharged to their GP [34]. There is no
costs to patients for attending outpatient clinics in NI.
Outpatient waiting lists are not available for diabetes
care.
In this study, we examine, for patients aged 50 and
over with diabetes, differences between NI and ROI in
the prevalence of diabetes and the number and type of
health care contacts (GP, Outpatient, A&E Visits and
Hospital Nights). Older people are the main population
of interest for examining health care utilisation by
people with diabetes given this is where the disease is
most prevalent – in the UK, 83% of people with diabetes
(type I and type II) are over the age of 50 [35, 36]. One
previous study, using different data sources, has previ-
ously compared the age adjusted prevalence of diabetes
between the two jurisdictions. Differences in entitlement
to care (including sub-groups differentiated by income
level) and utilization of care between the two parts of
Ireland have been explored previously for the overall
population [33, 37, 38]. As far at the authors are aware a
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needs adjusted comparison of health care utilisation by
people with diabetes is not available.
Methods
Data
The Irish Longitudinal Study on Aging (TILDA) and
Northern Irish Cohort for the Longitudinal Study of
Aging (NICOLA) surveys, used in this study, are based
on interviews and health assessments with a representa-
tive of the population aged 50 and over in both ROI and
NI (see [39, 40] for further details of the TILDA and
NICOLA studies, including design, methodology, and as-
sessments carried out). The health assessment com-
prised of a physical examination and a blood test carried
out by a nurse at a health centre.
The TILDA and NICOLA surveys are ideally designed
for comparison with each other due to the similarity in
the two surveys. Each survey consists of computer-
assisted personal interviewing (CAPI) surveys containing
identical questions on diabetes diagnosis and complica-
tions. Self-reported doctor diagnosed diabetes, directly
comparable across the two surveys, is used in this study.
The prevalence of diabetes is compared for age groups
between 50 and 84 as there are no observations with dia-
betes over the age of 84 in the TILDA data. Self-
reported health care utilisation variables examined in
this study were GP utilisation, outpatient, A&E and hos-
pital nights. Utilisation rates are all based on the previ-
ous 12 months. Survey work for TILDA was carried out
in 2011 (Wave 1), survey work for NICOLA was carried
out in 2014–2016 (Wave 1). Using the first wave of each
survey is advantageous as attrition in later waves may
not be at random. Estimates of the number of cases of
diabetes in NI are based on NICOLA age and gender
adusted prevalence rates and population estimates for
2014 [41].
Statistical approach
Matching is a method for rebalancing observational data
[42]. A key advantage of matching over regression ana-
lysis is a reduced dependence on assumptions about
functional form [43]. A Coarsened Exact Matching
(CEM) approach is used here to match observations in
the two jurisdictions and allow for a direct comparison
of outcomes. CEM is a type of matching process that in-
volves the temporary coarsening of continuous variables
followed by a direct matching between two groups. The
CEM method involves categorising continuous variables
into user defined groups. A stratum is created for each
unique observation in the data set. Observations are
dropped that do not have at least one observation from
the two groups in the stratum. Thus, the CEM process
involves pruning from both groups [44]. This method
was chosen over the Mahalanobis distance method of
matching as we wish to match on a combination of con-
tinuous and dichotomous variables [45].
Matching variables
Matching is done based on the presence and severity of
health needs. Health needs are captured in age, sex, edu-
cation, current smoking status, self-reported health, the
number of chronic illnesses and the number of diabetic
complications reported. Diabetic complications are de-
fined here as heart attack, stroke, leg ulcers, kidney dis-
ease, neuropathy, retinopathy and nephropathy. These
matching variables were selected based on previous find-
ings from TILDA of the covariates of health care utilisa-
tion [46]. A count of the number of diabetic
complications is included as this has been shown to cor-
relate with hospital utilisation [47]. Similarly, chronic ill-
nesses identified in the surveys were included in the
matching as a count as there is little indication that
more complex multi-morbidity indexes outperform a
simple count [48]. The available chronic illness in the
surveys are: chronic lung disease; asthma; arthritis;
osteoporosis; cancer; any emotional, nervous or psychi-
atric problems; alcohol or substance abuse; stomach ul-
cers; varicose ulcers; high blood pressure or
hypertension and angina. Body Mass Index (BMI), glyco-
sylated haemoglobin (HbA1c) and other biometric
markers are not included in the analysis of health care
utilisation as they are only available for the subsample
that attended the health assessment.
Number of observations
In total 17,008 people were surveyed (TILDA: 8504 and
NICOLA: 8504). Both studies contain a small number of
observations under 50 years included in the matching
process (TILDA: 329 and NICOLA: 195). There were 16,
681 observations (TILDA: 8468 and NICOLA: 8212)
with no missing data in the matching and outcome vari-
ables. The combined data set comprises complete sur-
veys from 1536 people with diabetes (TILDA: 634 and
NICOLA: 902). After the matching process there are a




Figure 1 shows the percentage of individuals who report
having received a diagnosis of diabetes from their doctor
by sex and age group in NI and ROI. The prevalence
rates for NI are higher across all age groups and genders.
The overall prevalence in the 50 to 84 years old age
group is 3.4 percentage points higher in NI (11.1% in NI,
7.7% ROI, p-value < 0.01). There are no observations in
ROI for those in the over 85 years age group.
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There is no indication from the data available that the
higher prevalence rates in NI are due to higher case as-
certainment. Among those for whom HbA1c data were
available, the rates of undiagnosed diabetes (HbA1c > 48
mmol/mol (6.5%) and no report of a diabetes diagnosis)
are also higher in NI (0.8% in ROI vs 4.4% in NI).
Health of people with diabetes
Table 1 shows the demographic and health status of the
samples of people with diabetes in ROI and NI. There
are no differences (p > 0.05) in the gender and current
smoking status of the two samples, the sample from NI
is slightly older. As previously reported, people in the NI
have significantly lower levels of self-reported good
health status and higher rates of education [49]. People
with diabetes in NI have substantially more complica-
tions related to diabetes; the proportion of people with
diabetes and two or more complications is 8.9 percent-
age points higher (p < 0.001) in NI. Rates of stroke, kid-
ney disease and neuropathy are all significantly higher in
NI. The number of other chronic diseases that people
with diabetes have is also higher in NI; the proportion of
people with diabetes, with three or more other chronic
conditions is 9.4 percentage points higher (p < 0.001) in
NI. Chronic lung disease, asthma, arthritis, alcohol or
substance abuse, emotional, nervous or psychiatric prob-
lems, hypertension and angina are all significantly higher
in NI (p < 0.05). In summary, the sample of people with
diabetes in NI appear substantially “sicker” than the
sample from ROI.
Health care utilisation
Table 2 shows the health care utilisation of people with
diabetes in NI and ROI before and after matching.
Matching is carried out based on age, sex, education,
smoking status, self-related health, number of diabetic
complications and number of chronic illnesses. The left
hand side of Table 2 shows the health care utilisation of
people with diabetes in both jurisdictions before match-
ing. There is no statistical difference between the GP
utilisation but outpatient visits; A&E visits and Hospital
nights are all significantly higher in NI. Interestingly
substantially more people in NI with diabetes reported
not having attended their GP in the last year (ROI 4.2%,
NI 7.9%, p-value = 0.006). A similar proportion of people
with diabetes attended an outpatient service in the past
12 months (ROI 38.9%, NI 38.2%, p-value = 0.79).
The right hand side of Table 2 shows the health care
utilisation of people with diabetes in both jurisdictions
after the matching process. The health care utilisation of
the NI group reduced in all areas of utilisation – this is
what you would expect as higher needs observations in
NI are pruned off in the matching process. After match-
ing for need, the difference between primary care utilisa-
tion in ROI and NI is now larger, but still not
statistically significant (ROI 5.6, NI 5.0, p-value = 0.108).
After matching for need, the difference between second-
ary care utilisation in ROI and NI is reduced, and in
most cases cease to be statistically significant. In the case
of inpatient nights however, NI patients continue to con-
sume significantly more care.
Discussion
In this study we compare the prevalence, health and pat-
terns of health care usage of people with diabetes in
Northern Ireland and the Republic of Ireland based on
two samples taken from representative cohort studies in
the respective jurisdictions.
The surveys show that on an age and gender adjusted
basis there is a substantially higher prevalence of dia-
betes in NI. This contrasts with the previous finding of
clinically equivalent prevalence rates of diabetes in NI
and ROI across all age groups [9]. The main difference
between this study and the previous study [9] is in the
NI prevalence rates. The rates of diabetes shown here
for ROI are in line with previous studies for ROI [9, 50,
51]. The rates of diabetes shown in the NICOLA data
are consistent with the total number of cases of diabetes
registered in Northern Ireland [7]. The estimated num-
ber of people over 50 with diabetes based on the NIC-
OLA prevalence rates was 67,941 in 2014. This
represents 83% of the 81,867 people in NI with a diagno-
sis of diabetes in the same year on the diabetes register.
This is in line with the proportion of people with dia-
betes who are over 50 in the rest of the UK [35, 36]. Our
results also show that among people with diabetes, those
in NI have more complications and more chronic ill-
nesses in general, than people with diabetes in ROI.
While it is possible that having a system like QOF may
have increased detection and diagnosis of certain condi-
tions, leading to greater prevalence in NI, this is not sup-
ported by the lower self-reported health and GP
Fig. 1 Prevalence of diabetes by gender and age category
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utilisation in the North. Therefore we believe it is not
likely that differences in the prevalence of diabetes, dia-
betic complications and chronic illness can be explained
by the differences in the healthcare system between the
two jurisdictions. We also find no indication from the
data available in the surveys that the higher prevalence
rates in NI are due to higher case ascertainment. While
alternative data sources for the rates of undiagnosed dia-
betes in ROI show substantially higher rates compared
to TILDA they are still lower than in NI [52].
Broader societal factors, that may include attitudes to
diet and physical exercise, other diseases or possibly cu-
mulative lifetime stress may also contribute to the differ-
ence in the prevalence rates. There is limited data
Table 1 Health and demogrpahic characterisitcs of older people with diabetes in ROI and NI (before matching)
ROI (TILDA) NI (NICOLA) p-
valuen n
Number of People with Diabetes 634 902
Age (Mean) 66.4 67.5 0.018
Male 365 58% 501 56% 0.430
Primary Education Only 260 41% 314 35% 0.014
Current Smoker 109 17% 148 16% 0.685
Good Self Related Health 320 50% 345 38% < 0.001
Diabetic Complications
None 403 64% 482 53% < 0.001
One 167 26% 249 28% 0.58
Two + 64 10% 171 19% < 0.001
Heart Attack 73 11.5% 127 14.1% 0.142
Stroke 40 6.3% 87 9.6% 0.020
Leg ulcers 24 3.8% 39 4.3% 0.601
Kidney disease 41 6.5% 129 14.3% < 0.001
Neuropathy (Nerve Endings) 90 14.2% 173 19.2% 0.011
Retinopathy 47 7.4% 83 9.2% 0.215
Nephropathy (Kidney) 23 3.6% 74 8.2% < 0.001
Treatment
Tablets 498 78.5% 678 75.2% 0.124
Insulin 107 16.9% 185 20.5% 0.074
Other Chronic diseases
None 113 18% 108 12% 0.001
One 215 34% 280 31% 0.230
Two 188 30% 261 29% 0.760
Three+ 118 19% 253 28% < 0.001
Chronic lung disease 30 4.7% 77 8.5% 0.004
Asthma 72 11.4% 134 14.9% 0.048
Arthritis 204 32.2% 382 42.4% < 0.001
Osteoporosis 34 5.4% 62 6.9% 0.229
Cancer 46 7.3% 84 9.3% 0.154
Any emotional, nervous or psychiatric problems 63 9.9% 142 15.7% 0.001
Alcohol or substance abuse 14 2.2% 37 4.1% 0.042
Stomach ulcers 47 7.4% 10 1.1% < 0.001
Varicose Ulcers 24 3.8% 53 5.9% 0.065
High blood pressure or hypertension 390 61.5% 602 66.7% 0.004
Angina 72 11.4% 143 15.9% 0.048
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available that allows for the direct comparison between
the two jurisdictions of health indicators relating to dia-
betes [53, 54]. From the available data it is not possible
to point towards a likely causal mechanism as to why
the North would have more diabetes – for example the
prevalence of obesity, levels of physical activity and
smoking are similar in the two jurisdictions [53].
Chronic stress, related to the protracted period of civil
unrest known as the “Troubles” may be one potential
explanation for differences [55] though this is
speculative.
People with diabetes typically have other chronic con-
ditions [56]. By adjusting for the “sickness” of the people
with diabetes in NI and ROI through matching we show
that health care utilisation with the exception of in-
patient care is similar in both jurisdictions despite differ-
ences in health care systems. While not statistically
significant, the results point towards a more primary
care focused service in ROI, with more frequent GP
visits and less frequent secondary care visits. A previous
comparison between the two jurisdiction of health care
utilisation in general similarly found a greater role
played by GPs in ROI [57].
Policies such as QOF and universal access to GP care
in NI might be expected to increase health care utilisa-
tion in NI, however, this appears not to be the case.
While direct financial incentives were not in place at the
time in ROI for diabetes care, the higher levels of pri-
mary care utilisation seen may relate to the greater avail-
ability of GPs in ROI where there are substantially more
GPs per capita [21, 22]. The suite of policies required to
improve the supply of GPs goes beyond a narrow set of
financial incentives, including increasing GP training in-
take [22]. The Cycle of Care policy was introduced in
ROI in 2015, subsequent to the TILDA data used in this
paper. This policy incentivises GPs to provide structured
annual reviews and improved records for people with
type 2 diabetes. While this may have improved patient
care in ROI [58] any decline in the availability of GPs
per capita in the future due to increased demand [59], or
supply factors such as training emigration or retirements
[22] may counteract any positive benefits in the long
run. In addition, the Cycle of Care scheme does not pro-
vide funding for patients without public medical cover,
which comprise 32% of people over 50 years of age with
diabetes [31].
It is also notable there is a higher prevalence among
people with diabetes in NI of non-attendance at the GP
in the past 12 months. As the cut points (proportion of
people with diabetes on a practices register) for pay-
ments, however, are currently set there are no financial
incentives to seek out the people who do not attend
once the practice reaches a certain cut off point. This
may contribute to poorer disease management and in
part explain the greater use of hospital services in
Northern Ireland. Higher levels of hospital inpatient util-
isation in Northern Ireland may also be due to higher
levels of hospital supply [60].
Limitations
The data used in this study are based on two large repre-
sentative cross sectional surveys. However there are a
number of limitations to our study. The presence of dia-
betes, complications, and health care utilisation are all
self-reported, running the risk of recall bias. However,
there is no reason to believe that recall bias would apply
differentially across jurisdictions. The study compares
aggregate differences in health care utilisation among
those with diabetes and not differences between sub-
groups among whom entitlements might differ. While
this may provide a fruitful avenue for future research, it
was considered to be beyond the scope of this current
work. The study considers type 1 and type 2 diabetes to-
gether. However the number of people with type 1 dia-
betes in the surveys is likely to be very small – in the
UK less that 4% of people over 50 with diabetes are type
1 [35].
The age and gender adjusted prevalence rates of dia-
betes and diabetic complications are compared at two
time points over 3 years apart; a comparison of these
rates on the same year may reduce or increase the scale
of the differences depending on the relative difference in




valueROI (TILDA) NI (NICOLA) ROI (TILDA) NI (NICOLA)
No. of people with diabetes 634 902 420 486
GP visits per year (mean including non-users) 5.7 5.6 0.668 5.6 5.0 0.108
GP visits: None 4.2% 7.9% 0.004 4.5% 9.3% 0.006
Outpatient visits per year (mean including non-users) 2.1 3.6 < 0.001 2.1 3.2 0.079
Outpatient Visits: None 38.9% 38.2% 0.79 40.0% 42.4% 0.47
A&E visits per year (mean including non-users) 0.3 0.5 0.010 0.3 0.4 0.290
Hospital nights per year (mean including non-users) 1.2 2.1 < 0.00 1.2 1.8 0.039
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the incidence of diabetes and complications in that 3
year period. A comparison cannot be made between
people with diabetes in the over 85 year old age group as
none are present in the TILDA data set. People with de-
mentia are similarly underrepresented in both TILDA
and NICOLA. The severity of reported health conditions
is not available in the data; the variation in health care
needs may not be fully captured by the number of
chronic illnesses or the number of diabetic complica-
tions. Only key aspects of health care utilisation (general
practitioner, outpatient or accident and emergency util-
isation) are compared in this study, other primary and
social care utilisation are not compared.
Conclusion
This study shows that the prevalence and severity of dia-
betes, among those aged 50 and over, is higher in North-
ern Ireland than in the Republic of Ireland. The study
shows that for cohorts with comparable health care
needs, with the exception of inpatients nights, there is
no significant difference in patterns of health care use.
The available data does not allow us to explain the
underlining reasons for differences in health care utilisa-
tion across the two jurisdictions. For GP utilisation,
there are a range of factors including the supply of GPs
and financial incentives of both GPs and patients that
will affect utilisation. The lack of difference in GP util-
isation, despite greater severity, combined with higher
rates of GP non-attendance in NI suggest a closer exam-
ination of primary care is worthy of investigation. How-
ever, it is useful for policy making to know that a
substantially different health care system can produce a
very similar pattern of utilisation.
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